BSE filing, NSE: KINGSINFR. Summary written from the filing by ALFA Finder's alert engine.
Kings Infra Ventures Ltd: key numbers
- Share price
- ₹60.00
- Market cap
- ₹147.0 Cr
- Revenue (annual)
- ₹160.8 Cr
- Net profit (annual)
- ₹16.15 Cr
- P/E (TTM)
- 9.9×Sector 26.8×
- Promoter holding
- 69.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kings Infra Ventures Ltd
All →Kings Infra Ventures Credit Rating
Infomerics downgraded credit ratings for Kings Infra Ventures' bank facilities and NCDs, citing non-cooperation. The rating action applies to existing debt instruments.
Kings Infra Ventures Annual General Meeting
Kings Infra Ventures Limited held its 38th Annual General Meeting virtually, where directors, auditors, and members attended to review the company's annual proceedings.
Kings Infra Ventures Management Change
Kings Infra Ventures appointed Mr. Akhil Haridas as Chief Financial Officer effective September 25, 2026. He succeeds Mr. Lalbert Cherian, who resigned from the position.
Kings Infra Ventures Board Meeting Date
Kings Infra Ventures Limited scheduled a board meeting on September 25, 2026, to consider and approve the appointment of a Chief Financial Officer.
Kings Infra Ventures Other Announcement
Kings Infra Ventures Limited announced the transmission of 1,11,300 equity shares from the late Mr. C Baby John to his legal heir, Ms. Annamma Baby John.
Kings Infra Ventures Debt & Borrowing: ₹0.92 Cr
Kings Infra Ventures allotted 9,220 secured redeemable NCDs aggregating Rs. 0.92 Crore via private placement. This is the 21st tranche of its unlisted secured NCD issuance.
- Value
- ₹0.92 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.